WHI Presentations

This page provides the videos, transcripts, slides and/or handouts for past WHI Annual Investigator Meetings. Please expand the year(s) of interest to view the relevant files. In addition, some years may include abstracts from accepted poster presentations.

Meetings/Presentations

Register here for the 2025 WHI Investigator meeting! We are excited to welcome everyone to this meeting at the Fred Hutch Cancer Center in Seattle, WA (The home of the WHI Clinical Coordinating Center). This year’s meeting will feature dinner at Waterways on South Lake Union and a Friday morning guided lakefront walk.

We are thrilled to welcome keynote speaker Dr. Rachel Whitmer. Dr. Whitmer is a tenured Professor of Public Health Sciences and Neurology, Chief of the Division of Epidemiology at the University of California Davis (UC Davis) School of Medicine and Co-director of the UC Davis Alzheimer’s Disease Research Center. She was the first female ‘Target of Excellence’ hire at UC Davis School of Medicine, a hiring mechanism to recruit high impact scientists who are internationally renowned experts in their fields and will bridge needed gaps in the research mission of the university.

The 2025 meeting will cover a range of topics of interest to researchers, and provide an opportunity for investigators to meet, interact, and share their insights. The confirmed Symposia include:
  • Migraine and Stroke Risk in Postmenopausal Women: The Role of WHI in Advancing Knowledge of Epidemiology, Mechanisms and Preventive Strategies
  • Evaluating the Cardiovascular-Kidney-Metabolic Syndrome in the WHI DEXA Cohort
  • Dementia risk and cognitive resilience
  • Disparities in cancer survivorship
  • Multi-omics resources and applications to WHI
The meeting will held at Fred Hutchinson Cancer Center, 1100 Fairview Ave N., Seattle, WA, 98109. Below you will find the hotel link to reserve your room within the WHI room block.

Please reserve your room by Monday, March 31, 2025 by five (5) pm Pacific Time (PT), to receive the group rate.
  1. Silver Cloud Lake Union - (Price $179 per night plus tax) – This is a 4-minute walk from the meeting location.
We look forward to seeing you at this year’s WHI Investigator meeting!

Full Program

Day 1

PresentationSpeakersVideo
Welcome/OverviewMarian Neuhouser, WHI Steering Committee Chair
Introduction of the Rebecca Jackson Lecturer
Unraveling dementia risk, brain health, and exceptional cognitive aging , clues across the life courseDr. Rachel Whitmer, Professor & Vice Chair of Research, Public Health Sciences University of California, Davis
Q&A
Plenary 1: Migraine and Stroke Risk in Postmenopausal Women: The Role of WHI in Advancing Knowledge of Epidemiology, Mechanisms and Preventive Strategies Chair: Tracy Madsen
Plenary 1: Migraine and Stroke: An Opportunity for Improved Stroke Prevention in Women Brian Silver, University of Massachusetts
Plenary 1: Migraine as a Risk Factor for Stroke across the Lifespan and Modification of Risk after MenopauseTracy Madsen, Larner College of Medicine, University of Vermont
Plenary 1: Migraine and Mechanism: The role of Inflammatory Biomarkers in the Link between Migraine and StrokeZailing Xing, Larner College of Medicine, University of Vermont
Plenary 1: The Future of Migraine Research in Postmenopausal WomenJelena Pavlovic, Albert Einstein College of Medicine
Plenary 1: Q&A
WHI ESI Award introductionIntroduction: Kerry Reding, University of Washington
PresentationAlexi Vasbinder, University of Washington School of Nursing
IGNITE
IGNITE 1: Genetic Risk Profiles Inform Personalized Hormone Therapy Decisions: Evidence from the Women's Health InitiativeHuong Le, Fred Hutchinson Cancer Center
IGNITE 2: Harnessing the Power of Multi-Omics to Advance Understanding of Biological Aging and Healthspan in Older WomenAladdin Shadyab, University of California San Diego
Q&A
CCC updatesGarnet Anderson, Fred Hutchinson Cancer Center
WHI Group Photo – Thomas StairsALL
Boxed lunch and panel discussion with SC about the future of WHIArnold – M1-A303/305/307 Behnke Suites
Plenary 2 - Dementia risk and cognitive resilience Chair: Lindsay Reynolds
Plenary 2: Plasma proteins related to inflammatory diet predict future cognitive impairmentMichael Duggan, NIA, NIH
Plenary 2: Proteomic analysis of APOEe4 carriers implicates lipid metabolism, complement and lymphocyte signaling in cognitive resilienceKeenan Walker, NIA/NIH
Plenary 2: Self-reported experiences of discrimination and incident dementiaMichael P. Bancks, Wake Forest University School of Medicine
Plenary 2: Blood based Alzheimer’s biomarkers and Dementia risk in the Women’s Health InitiativeMichelle Mielke, Wake Forest University School of Medicine
Q&A
Plenary 3 - Multi-omics resources and applications to WHIChair: Nora Franceschini
Plenary 3: Introduction and Background Nora Franceschini, University of North Carolina
Plenary 3: Epigenetics, diet and clinical outcomes Lindsay Reynolds, Wake Forest University
Plenary 3: Environmental epigenetics and chronic disease risk: enhancing risk prediction to address health disparities Andres Cardenas, Stanford University
Plenary 3: The Nutrition and Physical Activity Assessment Study (NPAAS) research program 2004- presentMarian Neuhouser, Fred Hutchinson Cancer Center
Plenary 3: Dietary Intake biomarker criteria and metabolomics-based biomarker findings in WHI cohortsRoss Prentice, Fred Hutchinson Cancer Center
Q&A

Day 2

PresentationSpeakersVideo
Optional 2k South Lake Union walkLed by CCC staff
Welcome/Overview of the dayMarian Neuhouser
Plenary 4 – Disparities in cancer survivorship Chair: Elizabeth Cespedes-Feliciano
Plenary 4: Introduction Elizabeth Cespedes-Feliciano, Kaiser Permanente, Division of Research
Plenary 4: Impact of cancer and its treatments on epigenetic and functional aging: understanding trajectories and potential interventionsAlexandra Binder, University of Hawaii Cancer Center
Plenary 4: Deficits Accumulation Index in WHI: Disparities by race in LILAC cancer survivor and non-cancer controlsSowmya Vasan, Fred Hutchinson Cancer Center
Plenary 4: Neighborhood deprivation and elevated deficit accumulation frailty score among older breast cancer survivors and non-cancer controlsEunji Choi, Cornell University
Plenary 4: Guideline-concordant breast cancer treatment between urban and rural in the Women's Health Initiative Life and Longevity after Cancer studyXiaochen Zhang,The Ohio State University
Q&A
Plenary 5 - Evaluating the Cardiovascular-Kidney-Metabolic Syndrome in the WHI DEXA CohortChair: Deepika Laddu
Plenary 5: IntroductionDeepika Laddu, Northwestern University
Plenary 5: WHI DEXA Cohort Stage 1 CKM: Visceral Adiposity/CKM Stage 2: What WHI can contributeJennifer Bea, University of Arizona
Plenary 5: CKM Stage 3 &4: WHI Visceral Fat and ASCVDAndy Odegaard, University of California Irvine
Plenary 5: CKM Stage 3 &4: WHI Visceral Fat and Heart FailureMichael LaMonte, University at Buffalo
Plenary 5: Next Steps for WHI to make a major contribution to CKM syndrome workDeepika Laddu
Q&A
Closing remarks and Wrap-up/Adjourn